ArticleEuropean urology2024
Updated Overall Survival by Circulating Tumor DNA Status from the Phase 3 IMvigor010 Trial: Adjuvant Atezolizumab Versus Observation in Muscle-invasive Urothelial Carcinoma.
Thomas Powles et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
84 papers cite itlatest 60 shown
this paperpooled itcites it